
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
1 Immunicon Corporation, Huntingdon Valley, Pennsylvania; and 2 Cancer Immunobiology Center and Departments of Microbiology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas
Purpose: The purpose of this study was to determine the accuracy, precision, and linearity of the CellSearch system and evaluate the number of circulating tumor cells (CTCs) per 7.5 mL of blood in healthy subjects, patients with nonmalignant diseases, and patients with a variety of metastatic carcinomas.
Experimental Design: The CellSearch system was used to enumerate CTCs in 7.5 mL of blood. Blood samples spiked with cells from tumor cell lines were used to establish analytical accuracy, reproducibility, and linearity. Prevalence of CTCs was determined in blood from 199 patients with nonmalignant diseases, 964 patients with metastatic carcinomas, and 145 healthy donors.
Results: Enumeration of spiked tumor cells was linear over the range of 5 to 1,142 cells, with an average recovery of
85% at each spike level. Only 1 of the 344 (0.3%) healthy and nonmalignant disease subjects had
2 CTCs per 7.5 mL of blood. In 2,183 blood samples from 964 metastatic carcinoma patients, CTCs ranged from 0 to 23,618 CTCs per 7.5 mL (mean, 60 ± 693 CTCs per 7.5 mL), and 36% (781 of 2,183) of the specimens had
2 CTCs. Detection of
2 CTCs occurred at the following rates: 57% (107 of 188) of prostate cancers, 37% (489 of 1,316) of breast cancers, 37% (20 of 53) of ovarian cancers, 30% (99 of 333) of colorectal cancers, 20% (34 of 168) of lung cancers, and 26% (32 of 125) of other cancers.
Conclusions: The CellSearch system can be standardized across multiple laboratories and may be used to determine the clinical utility of CTCs. CTCs are extremely rare in healthy subjects and patients with nonmalignant diseases but present in various metastatic carcinomas with a wide range of frequencies.
This article has been cited by other articles:
![]() |
S. J. Cohen, C. J. A. Punt, N. Iannotti, B. H. Saidman, K. D. Sabbath, N. Y. Gabrail, J. Picus, M. A. Morse, E. Mitchell, M. C. Miller, et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer Ann. Onc., July 1, 2009; 20(7): 1223 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. B. Goodman Jr., L. M. Fink, J. T. Symanowski, B. Wong, B. Grobaski, D. Pomerantz, Y. Ma, D. C. Ward, and N. J. Vogelzang Circulating Tumor Cells in Patients with Castration-Resistant Prostate Cancer Baseline Values and Correlation with Prognostic Factors Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1904 - 1913. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Okumura, F. Tanaka, K. Yoneda, M. Hashimoto, T. Takuwa, N. Kondo, and S. Hasegawa Circulating Tumor Cells in Pulmonary Venous Blood of Primary Lung Cancer Patients. Ann. Thorac. Surg., June 1, 2009; 87(6): 1669 - 1675. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pajer, V. Karafiat, V. Pecenka, D. Prukova, J. Dudlova, J. Plachy, P. Kasparova, and M. Dvorak Industasis, a Promotion of Tumor Formation by Nontumorigenic Stray Cells Cancer Res., June 1, 2009; 69(11): 4605 - 4612. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Leversha, J. Han, Z. Asgari, D. C. Danila, O. Lin, R. Gonzalez-Espinoza, A. Anand, H. Lilja, G. Heller, M. Fleisher, et al. Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer Clin. Cancer Res., March 15, 2009; 15(6): 2091 - 2097. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Talasaz, A. A. Powell, D. E. Huber, J. G. Berbee, K.-H. Roh, W. Yu, W. Xiao, M. M. Davis, R. F. Pease, M. N. Mindrinos, et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device PNAS, March 10, 2009; 106(10): 3970 - 3975. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Gallagher, M. I. Milowsky, N. Ishill, A. Trout, M. G. Boyle, J. Riches, M. Fleisher, and D. F. Bajorin Detection of circulating tumor cells in patients with urothelial cancer Ann. Onc., February 1, 2009; 20(2): 305 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Massard, A. Chauchereau, and K. Fizazi The quest for the 'bony Grail' of detecting circulating tumour cells in patients with prostate cancer Ann. Onc., February 1, 2009; 20(2): 197 - 199. [Full Text] [PDF] |
||||
![]() |
S. C. C. Wong, C. M. L. Chan, B. B. Y. Ma, E. P. Hui, S. S. M. Ng, P. B. S. Lai, M. T. Cheung, E. S. F. Lo, A. K. C. Chan, M. Y. Y. Lam, et al. Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients Clin. Cancer Res., February 1, 2009; 15(3): 1005 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Morgan, P. H. Lange, M. P. Porter, D. W. Lin, W. J. Ellis, I. S. Gallaher, and R. L. Vessella Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence Clin. Cancer Res., January 15, 2009; 15(2): 677 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Sieuwerts, J. Kraan, J. Bolt, P. van der Spoel, F. Elstrodt, M. Schutte, J. W. M. Martens, J.-W. Gratama, S. Sleijfer, and J. A. Foekens Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells J Natl Cancer Inst, January 7, 2009; 101(1): 61 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Olmos, H.-T. Arkenau, J. E. Ang, I. Ledaki, G. Attard, C. P. Carden, A. H. M. Reid, R. A'Hern, P. C. Fong, N. B. Oomen, et al. Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience Ann. Onc., January 1, 2009; 20(1): 27 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Sturgeon, M. J. Duffy, U.-H. Stenman, H. Lilja, N. Brunner, D. W. Chan, R. Babaian, R. C. Bast Jr., B. Dowell, F. J. Esteva, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers Clin. Chem., December 1, 2008; 54(12): e11 - e79. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hiraiwa, H. Takeuchi, H. Hasegawa, Y. Saikawa, K. Suda, T. Ando, K. Kumagai, T. Irino, T. Yoshikawa, S. Matsuda, et al. Clinical Significance of Circulating Tumor Cells in Blood from Patients with Gastrointestinal Cancers Ann. Surg. Oncol., November 1, 2008; 15(11): 3092 - 3100. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Pierga, F.-C. Bidard, C. Mathiot, E. Brain, S. Delaloge, S. Giachetti, P. de Cremoux, R. Salmon, A. Vincent-Salomon, and M. Marty Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial Clin. Cancer Res., November 1, 2008; 14(21): 7004 - 7010. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. de Bono, H. I. Scher, R. B. Montgomery, C. Parker, M. C. Miller, H. Tissing, G. V. Doyle, L. W.W.M. Terstappen, K. J. Pienta, and D. Raghavan Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer Clin. Cancer Res., October 1, 2008; 14(19): 6302 - 6309. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Alix-Panabieres, S. Riethdorf, and K. Pantel Circulating Tumor Cells and Bone Marrow Micrometastasis Clin. Cancer Res., August 15, 2008; 14(16): 5013 - 5021. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maheswaran, L. V. Sequist, S. Nagrath, L. Ulkus, B. Brannigan, C. V. Collura, E. Inserra, S. Diederichs, A. J. Iafrate, D. W. Bell, et al. Detection of Mutations in EGFR in Circulating Lung-Cancer Cells N. Engl. J. Med., July 24, 2008; 359(4): 366 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Eliane, M. Repollet, K. E. Luker, M. Brown, J. M. Rae, G. Dontu, A. F. Schott, M. Wicha, G. V. Doyle, D. F. Hayes, et al. Monitoring Serial Changes in Circulating Human Breast Cancer Cells in Murine Xenograft Models Cancer Res., July 15, 2008; 68(14): 5529 - 5532. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Cohen, C. J.A. Punt, N. Iannotti, B. H. Saidman, K. D. Sabbath, N. Y. Gabrail, J. Picus, M. Morse, E. Mitchell, M. C. Miller, et al. Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer J. Clin. Oncol., July 1, 2008; 26(19): 3213 - 3221. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Hayes and J. Smerage Is There a Role for Circulating Tumor Cells in the Management of Breast Cancer? Clin. Cancer Res., June 15, 2008; 14(12): 3646 - 3650. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nole, E. Munzone, L. Zorzino, I. Minchella, M. Salvatici, E. Botteri, M. Medici, E. Verri, L. Adamoli, N. Rotmensz, et al. Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications Ann. Onc., May 1, 2008; 19(5): 891 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sastre, M. L. Maestro, J. Puente, S. Veganzones, R. Alfonso, S. Rafael, J. A. Garcia-Saenz, M. Vidaurreta, M. Martin, M. Arroyo, et al. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables Ann. Onc., May 1, 2008; 19(5): 935 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pantel, C. Alix-Panabieres, and S. Riethdorf Circulating Tumor Cells: Detection and Clinical Relevance Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 603 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
M C. Miller, G. V Doyle, and L. W M M Terstappen Monitoring and Characterization of CTC in Cancer Patients Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 617 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Reed, A. Graham, R. S. Hoda, A. Khoor, E. Garrett-Mayer, M. B. Wallace, and M. Mitas A simple two-gene prognostic model for adenocarcinoma of the lung J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 627 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Carden, D. Olmos, and J. S. de Bono Validated and Qualified Biomarkers Are Critical to Optimizing Anticancer Drug Development: Potential Roles for the Study of Circulating Tumor Cells ASCO Educational Book, January 1, 2008; 2008(1): 166 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Danila, G. Heller, G. A. Gignac, R. Gonzalez-Espinoza, A. Anand, E. Tanaka, H. Lilja, L. Schwartz, S. Larson, M. Fleisher, et al. Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer Clin. Cancer Res., December 1, 2007; 13(23): 7053 - 7058. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Haluska, H. M. Shaw, G. N. Batzel, D. Yin, J. R. Molina, L. R. Molife, T. A. Yap, M. L. Roberts, A. Sharma, A. Gualberto, et al. Phase I Dose Escalation Study of the Anti Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors Clin. Cancer Res., October 1, 2007; 13(19): 5834 - 5840. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. He, H. Wang, L. C. Hartmann, J.-X. Cheng, and P. S. Low In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry PNAS, July 10, 2007; 104(28): 11760 - 11765. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. de Bono, G. Attard, A. Adjei, M. N. Pollak, P. C. Fong, P. Haluska, L. Roberts, C. Melvin, M. Repollet, D. Chianese, et al. Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor Clin. Cancer Res., June 15, 2007; 13(12): 3611 - 3616. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Saudemont, A. Hamrouni, P. Marchetti, J. Liu, N. Jouy, D. Hetuin, F. Colucci, and B. Quesnel Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1 Cancer Res., May 1, 2007; 67(9): 4491 - 4498. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Shaffer, M. A. Leversha, D. C. Danila, O. Lin, R. Gonzalez-Espinoza, B. Gu, A. Anand, K. Smith, P. Maslak, G. V. Doyle, et al. Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer Clin. Cancer Res., April 1, 2007; 13(7): 2023 - 2029. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Riethdorf, H. Fritsche, V. Muller, T. Rau, C. Schindlbeck, B. Rack, W. Janni, C. Coith, K. Beck, F. Janicke, et al. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System Clin. Cancer Res., February 1, 2007; 13(3): 920 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Budd, M. Cristofanilli, M. J. Ellis, A. Stopeck, E. Borden, M. C. Miller, J. Matera, M. Repollet, G. V. Doyle, L. W.M.M. Terstappen, et al. Circulating Tumor Cells versus Imaging--Predicting Overall Survival in Metastatic Breast Cancer. Clin. Cancer Res., November 1, 2006; 12(21): 6403 - 6409. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Hayes, M. Cristofanilli, G. T. Budd, M. J. Ellis, A. Stopeck, M. C. Miller, J. Matera, W. J. Allard, G. V. Doyle, and L. W.W.M. Terstappen Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival. Clin. Cancer Res., July 15, 2006; 12(14): 4218 - 4224. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Henry and D. F. Hayes Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer. Oncologist, June 1, 2006; 11(6): 541 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mimeault and S. K. Batra Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies Carcinogenesis, January 1, 2006; 27(1): 1 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Scher and C. L. Sawyers Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis J. Clin. Oncol., November 10, 2005; 23(32): 8253 - 8261. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Alix-Panabieres, X. Rebillard, J.-P. Brouillet, E. Barbotte, F. Iborra, B. Segui, T. Maudelonde, C. Jolivet-Reynaud, and J.-P. Vendrell Detection of Circulating Prostate-Specific Antigen-Secreting Cells in Prostate Cancer Patients Clin. Chem., August 1, 2005; 51(8): 1538 - 1541. [Full Text] [PDF] |
||||
![]() |
D. A. Smirnov, D. R. Zweitzig, B. W. Foulk, M. C. Miller, G. V. Doyle, K. J. Pienta, N. J. Meropol, L. M. Weiner, S. J. Cohen, J. G. Moreno, et al. Global Gene Expression Profiling of Circulating Tumor Cells Cancer Res., June 15, 2005; 65(12): 4993 - 4997. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Reinholz, A. Nibbe, L. M. Jonart, K. Kitzmann, V. J. Suman, J. N. Ingle, R. Houghton, B. Zehentner, P. C. Roche, and W. L. Lingle Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast Cancer Clin. Cancer Res., May 15, 2005; 11(10): 3722 - 3732. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fiegl, H. Denz, I. H. Kunkler, C. Tang, A. Y. Lin, A. C. Voogd, K. van Gestel, M. F. Ernst, M. Cristofanilli, L. W.M.M. Terstappen, et al. Circulating Epithelial Cells in Breast Cancer N. Engl. J. Med., December 2, 2004; 351(23): 2452 - 2454. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |